A Randomized Controlled Trial Investigating the Survival Benefit of Dose-Intensified Multidrug Combination Chemotherapy (LSG9) for Intermediate- or High-Grade Non-Hodgkin's Lymphoma: Japan Clinical Oncology Group Study 9002
2004 ◽
Vol 80
(4)
◽
pp. 341-350
◽
2005 ◽
Vol 35
(1)
◽
pp. 34-36
◽
2015 ◽
Vol 33
(15_suppl)
◽
pp. 3577-3577
◽
2005 ◽
Vol 35
(8)
◽
pp. 475-477
◽
2008 ◽
Vol 38
(7)
◽
pp. 504-506
◽
2002 ◽
Vol 32
(9)
◽
pp. 363-364
◽
2013 ◽
Vol 44
(1)
◽
pp. 97-100
◽
2019 ◽
Vol 3
(3)
◽
pp. 301-309
◽